journal article·2016-04Open access

α‐Galactosidase‐A Loaded‐Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration

Ingrid Cabrera, Ibane Abasolo, José L. Corchero, Elisa Elizondo, Pilar Rivera Gil, Evelyn Moreno, Jordi Faraudo, Santi Sala, Dolores Bueno, Elisabet González‐Mira, Merche Rivas, Marta Melgarejo, Daniel Pulido, Fernando Albericio, Miriam Royo, Antonio Villaverde, Maria F. García‐Parajo, Simó Schwartz, Nora Ventosa, Jaume Veciana

Advanced Healthcare Materials· Volume 5· Issue 7

Abstract

Lysosomal storage disorders (LSD) are caused by lysosomal dysfunction usually as a consequence of deficiency of a single enzyme required for the metabolism of macromolecules, such as lipids, glycoproteins, and mucopolysaccharides. For instance, the lack of α‐galactosidase A (GLA) activity in Fabry disease patients causes the accumulation of glycosphingolipids in the vasculature leading to multiple organ pathology. Enzyme replacement therapy, which is the most common treatment of LSD, exhibits several drawbacks mainly related to the instability and low efficacy of the exogenously administered therapeutic enzyme. In this work, the unprecedented increased enzymatic activity and intracellular penetration achieved by the association of a human recombinant GLA to nanoliposomes functionalized with Arginine‐Glycine‐Aspartic acid (RGD) peptides is reported. Moreover, these new GLA loaded nanoliposomes lead to a higher efficacy in the reduction of the GLA substrate named globotriasylceramide in a cellular model of Fabry disease, than that achieved by the same concentration of the free enzyme. The preparation of these new liposomal formulations by DELOS‐SUSP, based on the depressurization of a CO2‐expanded liquid organic solution, shows the great potential of this CO2‐based methodology for the one‐step production of protein‐nanoliposome conjugates as bioactive nanomaterials with therapeutic interest.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lysosomal Storage Disorders Research · Advanced Drug Delivery Systems · Carbohydrate Chemistry and Synthesis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut de Ciència de Materials de Barcelona (ICMAB‐CSIC) Campus Universitari de Bellaterra 08193 Cerdanyola del Vallès Spain

Centro de Investigación Biomédica en Red–Bioingeniería Biomateriales y Nanomedicina (CIBER‐BBN) Spain

CIBBIM‐Nanomedicine Vall d'Hebron Institut de Recerca (VHIR) Universitat Autònoma de Barcelona 08035 Barcelona Spain

Departament de Genètica i de Microbiologia Institut de Biotecnologia i de Biomedicina Universitat Autònoma de Barcelona 08193 Bellaterra Spain

ICFO‐Institut de Ciencies Fotoniques Mediterranean Technology Park 08860 Castelldefels Barcelona Spain

Combinatorial Chemistry Unit Barcelona Science Park Baldiri Reixac 10 08028 Barcelona Spain

Institute for Research in Biomedicine Barcelona Science Park 08028 Barcelona Spain

Department of Organic Chemistry University of Barcelona 08028 Barcelona Spain

ICREA‐Institució Catalana de Recerca i Estudis Avançats 08010 Barcelona Spain

References (49)

Show source-provided references
1. 10.7326/0003-4819-138-4-200302180-0001410.7326/0003-4819-138-4-200302180-00014 ↗
2. 10.1056/NEJM20010705345010210.1056/NEJM200107053450102 ↗
3. 10.2165/11318300-000000000-0000010.2165/11318300-000000000-00000 ↗
4. 10.1016/j.ymgme.2012.08.00310.1016/j.ymgme.2012.08.003 ↗
5. Desnick RJ I. Y. · 2001 · 3733
6. 10.1016/j.tcm.2007.02.00610.1016/j.tcm.2007.02.006 ↗
7. 10.1016/j.ymgme.2008.06.01610.1016/j.ymgme.2008.06.016 ↗
8. 10.1016/j.ymgme.2014.08.00210.1016/j.ymgme.2014.08.002 ↗
9. Fervenza F. C. · Biol. Targets Ther. · 2008 · 2 · 823
10. 10.1023/A:101245542101410.1023/A:1012455421014 ↗
11. 10.1021/bm200338410.1021/bm2003384 ↗
12. 10.1038/sj.gt.330209210.1038/sj.gt.3302092 ↗
13. 10.1016/j.ymthe.2006.01.00610.1016/j.ymthe.2006.01.006 ↗
14. 10.1038/nrd70810.1038/nrd708 ↗
15. 10.1038/mt.2009.5310.1038/mt.2009.53 ↗
16. 10.1111/j.1742-4658.2007.06041.x10.1111/j.1742-4658.2007.06041.x ↗
17. 10.1016/j.jconrel.2010.10.03110.1016/j.jconrel.2010.10.031 ↗
18. 10.1016/S0142-9612(03)00331-410.1016/S0142-9612(03)00331-4 ↗
19. 10.1002/anie.20120801910.1002/anie.201208019 ↗
20. 10.1021/nl902697j10.1021/nl902697j ↗
21. 10.1073/pnas.080513510510.1073/pnas.0805135105 ↗
22. 10.1038/nnano.2013.19610.1038/nnano.2013.196 ↗
23. 10.1021/nn305929510.1021/nn3059295 ↗
24. 10.1021/la703210910.1021/la7032109 ↗
25. 10.1021/nl401707210.1021/nl4017072 ↗
26. 10.1039/b923535n10.1039/b923535n ↗
27. 10.1208/aapsj090201510.1208/aapsj0902015 ↗
28. Kubo T. · Int. J. Oncol. · 2000 · 17 · 309
29. N.Ventosa J.Veciana I.Cabrera E.Elizondo M.Melgarejo M.Royo F.Albericio D.Pulido S.Sala J. L.Corchero S.Schwartz I.Abasolo A.Villaverde WO2014/001509 2012.
30. 10.1084/jem.2008127810.1084/jem.20081278 ↗
31. 10.1089/rej.2009.092010.1089/rej.2009.0920 ↗
32. 10.1016/S0009-8981(98)00169-710.1016/S0009-8981(98)00169-7 ↗
33. 10.1002/btpr.63710.1002/btpr.637 ↗
34. 10.1038/nmat244210.1038/nmat2442 ↗
35. 10.1016/j.bej.2012.05.00310.1016/j.bej.2012.05.003 ↗
36. 10.1016/j.nantod.2014.02.00510.1016/j.nantod.2014.02.005 ↗
37. 10.1016/j.jmb.2004.01.03510.1016/j.jmb.2004.01.035 ↗
38. 10.1110/ps.06212610610.1110/ps.062126106 ↗
39. 10.1073/pnas.110505710810.1073/pnas.1105057108 ↗
40. 10.1083/jcb.20091010410.1083/jcb.200910104 ↗
41. Haviv Y. S. · Cancer Res. · 2002 · 62 · 4273
42. 10.1097/01.GIM.0000069509.57929.CD10.1097/01.GIM.0000069509.57929.CD ↗
43. 10.1086/31695310.1086/316953 ↗
44. A European Medicines Agency Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product. EMA/CHMP/806058/2009/Rev.02 http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_conten_t000564.jsp&mid=WC0b01ac05806403e0 2013.
45. Desnick R. J. · J. Lab. Clin. Med. · 1973 · 81 · 157
46. 10.1016/0009-8981(81)90384-310.1016/0009-8981(81)90384-3 ↗
47. 10.1681/ASN.200504038310.1681/ASN.2005040383 ↗
48. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗
49. Feynman R. · Eng. Sci. · 1960 · 23 · 22